Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tetracyclines affect prion infectivity.

Gianluigi Forloni1, Selina Iussich, Tazeen Awan

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Istituto Nazionale Neurologico Carlo Besta, and Istituto di Microbiologia e Immunologia Veterinaria, Università degli Studi, 20100 Milano, Italy.

Proceedings of the National Academy of Sciences of the United States of America
|August 1, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026
Same author

Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.

Discover nano·2026
Same author

D178N prion protein mutation endows RML prions with new strain properties that do not mimic human genetic prion diseases.

Acta neuropathologica·2026
Same author

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Brain sciences·2026
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles
This summary is machine-generated.

Tetracyclines, including doxycycline, reduce prion infectivity by directly interacting with abnormal prion proteins (PrPSc). This antibiotic treatment delays disease onset and prolongs survival in animal models, suggesting potential for prion disease prevention.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • Prion diseases are fatal neurodegenerative disorders with no effective treatments.
  • Abnormal prion protein aggregates (PrPSc) are key to disease transmission and pathogenesis.
  • Tetracyclines have shown potential in vitro to correct PrP abnormalities.

Purpose of the Study:

  • To investigate the efficacy of tetracyclines in reducing prion infectivity and disease progression.
  • To determine if tetracyclines interact with PrPSc from human (vCJD) and animal (BSE) sources.
  • To evaluate tetracyclines as a therapeutic or preventative strategy for prion diseases.

Main Methods:

  • In vitro incubation of PrPSc with tetracycline hydrochloride and doxycycline hyclate.
  • Assessment of protease resistance of PrPSc after tetracycline treatment.

Related Experiment Videos

  • Intracerebral inoculation of Syrian hamsters with scrapie-infected brain homogenate pre-treated with tetracyclines.
  • Monitoring of clinical signs, survival, magnetic resonance imaging, and neuropathological changes in hamsters.

    • Main Results:

    • Tetracyclines dose-dependently decreased the protease resistance of PrPSc.
    • Hamsters receiving tetracycline-treated inoculum showed delayed clinical signs and prolonged survival.
    • Neuropathological changes and PrPSc accumulation were delayed in treated hamsters.
    • A subset of hamsters receiving diluted, tetracycline-treated inoculum did not develop disease.

    Conclusions:

    • Tetracyclines directly interact with PrPSc, reducing prion infectivity.
    • These antibiotics show promise for inactivating contaminated materials and preventing prion diseases like vCJD and BSE.
    • Further research into tetracyclines as prion disease therapeutics is warranted.